Tel Aviv Sourasky Medical Center (TASMC)
Tel Aviv, Israel
NCT Number: NCT04182165
This is a single-center, prospective study in subjects visiting TASMC for various indications.
This study will be divided into two arms:
First Arm - Subjects measured by the study staff via the investigational device at the hospital (up to 50 subjects).
Second Arm - subjects measuring themselves autonomously with the investigational device at their homes (up to 10 subjects from the first arm).
Hence, total number of subjects for the study will be up to N=50. All subjects will be enrolled to the study only after signing an informed consent form.
Specifically for the second arm, subjects will undergo proper training by the sponsor's representatives prior to being discharged from the hospital. Training will focus on proper operation of the device, which is also designed for autonomous use in a simple and user-friendly manner. Subjects will be asked to monitor themselves periodically for a duration of up to a week. Ongoing support will be provided by the sponsor upon subject request, either by phone, or on-premise via a dedicated support team.
For both arms, device users (either study staff in first arm or subjects in the second arm) will be requested to answer questionnaires in order to assess usability with the investigational device. In both cases, a dedicated sponsor representative will observe the users to gather objective usability data, and aid in the questionnaire filling process.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Tel Aviv, Israel
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Usability study
Time frame: During the procedure
Time frame: During the procedure
Time frame: During the procedure
Time frame: During the procedure
The Gili System functions without physical contact with the inspected subject and is designed as a class 1 laser product (fully eye safe). Consequently, we do not expect any safety issues. At the same time, any AEs occurring during both trial stages will be recorded in the CRF.
ContinUse Biometrics Ltd.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05608967
Prehabilitation, Usability
Elche, Alicante, Spain
View Trial DetailsNCT05937646
Behavior, Communication
Chapel Hill, North Carolina, United States
View Trial DetailsNCT05318287
Grief, Traumatic Stress
Springfield, Oregon, United States
View Trial DetailsNCT06046053
Acceptability, Safety
Pittsburgh, Pennsylvania, United States
View Trial Details